Clinical Trial Update: Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease [Phase 2]

View source ↗

Summary

Phase 2 trial update on oral DS102 for chronic obstructive pulmonary disease completed; safety and efficacy data reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• DS102

Snippet

Sponsor: Afimmune | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED